Sage Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Sage Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sage Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sage Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers and develops medicines for central nervous system disorders. Focus on R&D activities, proprietary chemistry platform, and its lead product: Zurzuvae are its strengths, even as a history of operating losses is a major cause for concern to the company. The company could benefit from the growing market for epilepsy, growing market for major depressive disorder, and product pipeline. However, intense competition, dependence on third-party manufacturers, and stringent regulations could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer